Freenomecrunchbase

FreenomeFreenomeisabiotechnologycompanywithacomprehensivemultiomicsplatformforcancerdetectionusingaroutineblooddraw.,Freenomeraised$160000000on2019-07-24inSeriesB.,Freenomeisabiotechnologycompanywithacomprehensivemultiomicsplatformforcancerdetectionusingaroutineblooddraw.,Freenomeraised$270000000on2020-08-26inSeriesC.,Freenomeisabiotechnologycompanywithacomprehensivemultiomicsplatformforcancer...

參考資訊如下
Freenome acquires Oncimmune - 2023-05

Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Series B - Freenome - 2019-07

Freenome raised $160000000 on 2019-07-24 in Series B.

Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Series C - Freenome - 2020-08

Freenome raised $270000000 on 2020-08-26 in Series C.

Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Series D - Freenome - 2021-12

Freenome raised $300000000 on 2021-12-07 in Series D.

Freenome

Their latest funding was raised on Jan 11, 2022 from a Corporate Round round. Freenome is funded by 50 investors.

Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.